The FDA has issued a CRL to Saol Therapeutics regarding the NDA for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex deficiency.
AZoLifeSciences on MSN
Scientists Engineer E. Coli To Produce Plastic-Building Chemical
This study reveals a novel pathway in E. coli for synthesizing 2,5-pyridinedicarboxylate from glucose, offering a sustainable alternative to fossil fuels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback